Richard A. Farley

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Profil

Richard A.
Farley worked as Vice President-Human Resources at Shire ViroPharma, Inc. and XenoPort, Inc. before joining FibroGen, Inc. where he held the position of Vice President-Human Resources from 2015 to 2021.
Farley holds an MBA from Duke University and an undergraduate degree from Syracuse University.

Ehemalige bekannte Positionen von Richard A. Farley

Unternehmen	Position	Ende
FIBROGEN, INC.	Human Resources Officer	01.07.2021
XENOPORT, INC.	Human Resources Officer	-
Shire ViroPharma, Inc. Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA.	Human Resources Officer	-

Sehen Sie sich die Erfahrung von Richard A. Farley im Detail an

Ausbildung von Richard A. Farley

Duke University	Masters Business Admin
Syracuse University	Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Richard A. Farley im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
FIBROGEN, INC.	Health Technology

Private Unternehmen	2
Shire ViroPharma, Inc. Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA.	Health Technology
XenoPort, Inc. XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA.	Health Technology